← All trials
NCT04458311
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2020
- Primary completion
- Oct 1, 2023
- Completion date
- Oct 1, 2024
- First posted
- Jul 7, 2020
- Last posted
- Dec 28, 2020
- Enrollment
- 55
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of LondonLead sponsor
- Sun PharmaceuticalsCollaborator
- National Health Service, United KingdomStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.